AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20349405
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acids (1.7 g for three months)
Trial: 18751997
Drug: 2DW (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2DW (n = 25) - participated in 90‐min group training twice a week for 12 weeks
Trial: 11413076
Drug: Lamifiban (an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamifiban (an intravenous GP IIb/IIIa antagonist)
Trial: 9786314
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) administered by prolonged infusion
Trial: 9786314
Drug: New topoisomerase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New topoisomerase I inhibitor irinotecan
Trial: 28653108
Drug: Antioxidant-containing ointment
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant-containing ointment applied topically for 16 weeks, starting 3 days prior to chemotherapy.
Trial: 28653108
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment applied topically for 16 weeks, starting 3 days prior to chemotherapy.
Trial: 21569300
Drug: Problem solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem solving therapy, postcards, patient support, cultural assessment, improved access to primary care, risk management strategy
Trial: 16531621
Drug: G‐CSF (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF (10 microg/kg of body weight) for 6 days
Trial: 29633621
Drug: Ordinary hen
RxNorm normalized name: ordinary salt combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary hen eggs (3 eggs daily, 277 mg omega-3 PUFAs/day for 3 weeks)
Trial: 24390764
Drug: Fasudil (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasudil (30 mg intravenously twice a day for 14 days)
Trial: 21430703
Drug: 0.75% LDE225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% LDE225 cream
Trial: 18829872
Drug: Acute and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute and maintenance interpersonal and social rhythm therapy
Trial: 11386413
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not treated with chemotherapy)
Trial: 12763216
Drug: Temozolomide 200
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide 200 mg/m(2)/day, administered orally for 5 consecutive days of a 28-day cycle, continued for up to six cycles.
Trial: 11141365
Drug: Ibuprofen suspension
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen suspension (7 mg/kg)
Trial: 11141365
Drug: Effervescent granules
RxNorm normalized name: Klorvess Effervescent Granules for Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effervescent granules (200 mg for 25-40 kg; 400 mg for 35-40 kg; 400 mg for >40 kg)
Trial: 2841841
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g soy polysaccharide
Trial: 3012991
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g soy polysaccharide
Trial: 19954383
Drug: Intermittent preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent preventive treatment with sulfadoxine‐pyrimethamine (IPTp-SP) in HIV-negative mothers
Trial: 19954383
Drug: Intermittent preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent preventive treatment with sulfadoxine‐pyrimethamine (IPTp-SP)
Trial: 7105818
Drug: Cefaclor, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor, 150 mg 3-times daily
Trial: 7105818
Drug: Amoxycillin, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin, 150 mg 3-times daily
Trial: 24589242
Drug: Bromelain (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromelain (4 × 250 mg)
Trial: 24589242
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (4 × 25 mg)
Trial: 8349067
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg/d)
Trial: 22070512
Drug: Ilaprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole (10 mg/d)
Trial: 12200812
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of recombinant human EPO (rHuEPO) in groups A and C1
Trial: 12200812
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of rHuEPO in groups B and C2
Trial: 6182469
Drug: Starch-blocker tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Starch-blocker tablets
Trial: 31646767
Drug: Single 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 10 mg/kg intravenous dose of methylprednisolone
Trial: 31646767
Drug: Higher (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher (30 mg/kg) or more frequent (twice) dosing of methylprednisolone
Trial: 1622175
Drug: Fleroxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin (400 mg) administered orally and intravenously
Trial: 29106448
Drug: LMWH enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LMWH enoxaparin (1 mg/kg)
Trial: 26216477
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g GAA/kg diet
Trial: 26216477
Drug: 0.6 g
RxNorm normalized name: Ceo-Two, 0.9 g-0.6 g rectal suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 g GAA/kg diet
Trial: 26216477
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g GAA/kg diet
Trial: 26216477
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g GAA/kg diet with 0 g ARG/kg diet
Trial: 26216477
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g GAA/kg diet with 3 g ARG/kg diet
Trial: 26216477
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g GAA/kg diet with 6 g ARG/kg diet
Trial: 26216477
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g GAA/kg diet with 9 g ARG/kg diet
Trial: 12970285
Drug: recombinant luteinizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant luteinizing hormone (r-LH) 1 mg (n = 13)
Trial: 427002
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg i.v. pindolol
Trial: 427002
Drug: Oral pindolol
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pindolol (5, 10, and 20 mg)
Trial: 31655883
Drug: Local corticosteroid
RxNorm normalized name: Corticosteroids acting locally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local corticosteroid injection (LCI)
Trial: 30116006
Drug: 8-mg ondansetron
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-mg ondansetron
Trial: 30116006
Drug: 16-mg ondansetron
RxNorm normalized name: ondansetron 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16-mg ondansetron
Trial: 30116006
Drug: 24-mg ondansetron
RxNorm normalized name: ondansetron 24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-mg ondansetron
Trial: 27471856
Drug: Neonatal vitamin
RxNorm normalized name: NEONATAL VITAMIN Tablet
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neonatal vitamin A supplementation (single dose of 50,000 international units within 48-72 hours after birth)
Trial: 25552328
Drug: 4:1 mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4:1 mixture of 9 mg/ml propofol and 2.25 mg/ml ketamine (Group 2)
Trial: 25552328
Drug: 2:1 mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2:1 mixture of 9 mg/ml propofol and 4.5 mg/ml ketamine (Group 1)
Trial: 19135574
Drug: Carra/LNG gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carra/LNG gel (0.75 mg in 4 mL) with sexual intercourse after 2-4 hours
Trial: 19135574
Drug: Carra/LNG gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carra/LNG gel (0.75 mg in 4 mL) with abstinence
Trial: 26224101
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml of water
Trial: 9211770
Drug: Iodixanol (Visipaque
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol (Visipaque 270 mg I/ml)
Trial: 14616202
Drug: Iomeprol (Iomeron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iomeprol (Iomeron 300 mg I/ml)
Trial: 21196806
Drug: Inpatient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient treatment
Trial: 6969194
Drug: aspirin 600
RxNorm normalized name: aspirin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspirin 600 mg t.d.s.
Trial: 29800130
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of nitric oxide (iNO)
Trial: 24517173
Drug: Personalized oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized oxycodone dosing based on CYP2D6 phenotype testing and clinical pharmacokinetics.
Trial: 24517173
Drug: CYP2D6 phenotype
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYP2D6 phenotype testing and pharmacokinetics analysis.
Trial: 8749696
Drug: Urinary beta
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary beta 2‐microglobulin excretion > 500 ng/min
Trial: 8749696
Drug: Urinary beta
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary beta 2‐microglobulin excretion < or = 500 ng/min
Trial: 30629458
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acid supplementation (5 g/d)
Trial: 17114017
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor (PPI) therapy
Trial: 15478853
Drug: Endoscopic therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic therapies
Trial: 11874940
Drug: 45 mg
RxNorm normalized name: lutein 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 mg pioglitazone
Trial: 9091801
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg orally every 12 hours for five days)
Trial: 8371190
Drug: Topical APF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical APF gel (1.2% F‐) with daily use of placebo mouthrinse (Group B)
Trial: 8371190
Drug: Fluoridated mouthrinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoridated mouthrinse daily, ACT (0.05% F‐) (Group C)
Trial: 8371190
Drug: Placebo mouthrinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo mouthrinse daily (Group A)
Trial: 18339792
Drug: B-type natriuretic
RxNorm normalized name: B-type natriuretic peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B-type natriuretic peptide (BNP) levels in patients requiring ICU treatment
Trial: 15735109
Drug: Daily dose
RxNorm normalized name: LENVIMA 8mg Daily Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dose of iron (DI)
Trial: 15735109
Drug: Weekly dose
RxNorm normalized name: XPOVIO 60 MG Weekly Dose Carton Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly dose of multiple micronutrients
Trial: 12889590
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment (metronidazole plus erythromycin)
Trial: 1425054
Drug: Diosmin (Daflon);
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diosmin (Daflon); 12 tablets in three divided doses for the first four days, then 2 tablets twice daily for another 10 days.
Trial: 3936108
Drug: Clonidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (200 micrograms IV infusion)
Trial: 28915286
Drug: IVM+BR (Ivermectin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVM+BR (Ivermectin 1% cream and Brimonidine 0.33% gel)
Trial: 23663749
Drug: Advancing Recovery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advancing Recovery Framework (payer and treatment organization changes)
Trial: 23663749
Drug: Treatment organization
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment organization changes alone
Trial: 15656523
Drug: Routine group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine group (standard root canal therapy procedures)
Trial: 15656523
Drug: Medicament group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicament group (dexamethasone tablets after instrumentation)
Trial: 11134469
Drug: Zidovudine (ZDV)
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV) 300 mg twice daily from 36 weeks' gestation until labor, then every 3 hours until delivery
Trial: 3116443
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of azathioprine and OKT3
Trial: 29910054
Drug: Optimal Medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal Medical Therapy (OMT) alone
Trial: 31747093
Drug: Unpasteurised maternal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unpasteurised maternal milk (MM) intake (mL/kg/d)
Trial: 30739837
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy (CCRT) with weekly cisplatin regimen
Trial: 16792559
Drug: 4-methylpyrazole (4-MP)
RxNorm normalized name: 4-methylpyrazol
DrugBank: Fomepizole (DB01213)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-methylpyrazole (4-MP) treatment before ethanol consumption
Trial: 16792559
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment before ethanol ingestion
Trial: 28933336
Drug: Oxycodone once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone once-daily (OOD) 10 mg (oxycodone HCL 10-mg PR tablets XL)
Trial: 28933336
Drug: Oxycodone twice-daily
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxycodone twice-daily (OTD) 5 mg (oxygens 5-mg tablets)
Trial: 9562231
Drug: Combined administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined administration of cephalosporins and aminoglycosides
Trial: 20799359
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (80 ppm)
Trial: 7930234
Drug: Nitroprusside (maximally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroprusside (maximally tolerated dose)
Trial: 29386313
Drug: Regorafenib 160
RxNorm normalized name: Regorafenib
DrugBank: Regorafenib (DB08896)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Regorafenib 160 mg orally once daily for the first 21 days of each 28-day cycle
Trial: 23423269
Drug: Continuous corticosteroid
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous corticosteroid therapy (CCS)
Trial: 17728331
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ETN + MTX)
Trial: 17728331
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (previously receiving MTX or ETN monotherapy)
Trial: 11726257
Drug: Moderate Load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate Load (ML) - 13-15 repetitions with a moderate load on the chest press exercise, n = 16
Trial: 11726257
Drug: Medicine Ball
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine Ball (MB) - 13-15 medicine ball chest passes, n = 11
Trial: 2821052
Drug: Naloxone (10-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (10-mg iv bolus dose followed by an infusion of 30 micrograms/kg . h)
Trial: 23355361
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of ranolazine 500 mg twice daily for 7 days
Trial: 9840848
Drug: Ropivacaine at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine at 10 mL/hour
Trial: 8030688
Drug: Sequential estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential estradiol and norethindrone acetate (Trisequens)
Trial: 1176289
Drug: Kallikrein (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kallikrein (a kinin-liberating proteinase) administered parenterally and orally over a period of seven weeks.
Trial: 1176289
Drug: Parenteral application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral application of kallikrein.
Trial: 1176289
Drug: Kallikrein treatment.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kallikrein treatment.
Trial: 29790405
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education intervention during 6-month therapy
Trial: 25414475
Drug: Benztropine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benztropine (2 mg intramuscular)
Trial: 21903010
Drug: Comprehensive physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive physical therapy (PT)
Trial: 11315533
Drug: Conjoint family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjoint family therapy and eclectic approach
Trial: 8952239
Drug: Intraoral lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoral lidocaine patches
Trial: 6996784
Drug: Pseudoephedrine and
RxNorm normalized name: Pseudoephedrine and terfenadine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine and triprolidine combination
Trial: 31791405
Drug: Interactive tablet-based
RxNorm normalized name: Menin-mll interaction inhibitor ko 539
DrugBank: Ziftomenib (DB17171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive tablet-based education intervention
Trial: 22443058
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (8 mg daily of ferric pyrophosphate and ferrous fumarate)
Trial: 18713232
Drug: Calcium dobesilate
RxNorm normalized name: CALCIUM DOBESILATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dobesilate 1 g twice per day
Trial: 11840097
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL 0.9% saline
Trial: 10803112
Drug: Hytac (HY)
RxNorm normalized name: chlorpheniramine tannate / hydrocodone tannate Extended Release Suspension [HyTan]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hytac (HY) with both polymerization modes without preparation
Trial: 10803112
Drug: Dyract (DY)
RxNorm normalized name: dextromethorphan hydrobromide Disintegrating Oral Tablet [Duract Cough]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dyract (DY) with softstart-polymerization (SSP) without preparation
Trial: 29250843
Drug: Cinnamon powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnamon powder capsules 1.5 g/day in 3 divided doses for 12 weeks
Trial: 31621982
Drug: Electroacupuncture (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture (EA) treatment
Trial: 15175561
Drug: Nifedipine capsules
RxNorm normalized name: Nifedipine Capsules
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine capsules (2 x 10 mg doses given q8h for a total of three doses)
Trial: 15175561
Drug: Nifedipine prolonged
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine prolonged action tablets (20 mg doses given q12h for a total of two doses)
Trial: 15175561
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS tablet (60 mg single dose)
Trial: 8470059
Drug: Heparin (small
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (small amounts detected in AT-III concentrates)
Trial: 31281181
Drug: FA +
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: FA + L-thyroxine
Trial: 27891160
Drug: Antiretroviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral treatment
Trial: 11298132
Drug: No antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiretroviral treatment
Trial: 3528718
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no human albumin therapy)
Trial: 27633174
Drug: Probiotic treatment
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic treatment (Lactobacillus casei Shirota)